BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 15724844)

  • 21. Topical hexylaminolevulinate and aminolevulinic acid photodynamic therapy: complete arteriole vasoconstriction occurs frequently and depends on protoporphyrin IX concentration in vessel wall.
    Middelburg TA; de Bruijn HS; Tettero L; van der Ploeg van den Heuvel A; Neumann HA; de Haas ER; Robinson DJ
    J Photochem Photobiol B; 2013 Sep; 126():26-32. PubMed ID: 23892187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
    Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy.
    Loh CS; MacRobert AJ; Bedwell J; Regula J; Krasner N; Bown SG
    Br J Cancer; 1993 Jul; 68(1):41-51. PubMed ID: 8318419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer.
    Marti A; Jichlinski P; Lange N; Ballini JP; Guillou L; Leisinger HJ; Kucera P
    J Urol; 2003 Aug; 170(2 Pt 1):428-32. PubMed ID: 12853792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protoporphyrin IX-accumulation in human tumor cells following topical ALA- and h-ALA-application in vivo.
    Zenzen V; Zankl H
    Cancer Lett; 2003 Dec; 202(1):35-42. PubMed ID: 14643024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral aminolevulinic acid induces protoporphyrin IX fluorescence in psoriatic plaques and peripheral blood cells.
    Bissonnette R; Zeng H; McLean DI; Korbelik M; Lui H
    Photochem Photobiol; 2001 Aug; 74(2):339-45. PubMed ID: 11547574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of administration methods on the accumulation of ALA-induced Pp-IX in mouse tongue tumors.
    Ogasawara T; Miyoshi N; Sano K; Kitagawa Y; Yamada T; Ogawa T; Miyauchi K; Kinoshita H
    Oral Dis; 2006 Jul; 12(4):415-9. PubMed ID: 16792728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
    Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical application of 5-aminolaevulinic acid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin.
    Juzeniene A; Juzenas P; Ma LW; Iani V; Moan J
    Br J Dermatol; 2006 Oct; 155(4):791-9. PubMed ID: 16965430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics and localisation of PpIX fluorescence after topical and systemic ALA application, observed in skin and skin tumours of UVB-treated mice.
    van der Veen N; de Bruijn HS; Berg RJ; Star WM
    Br J Cancer; 1996 Apr; 73(7):925-30. PubMed ID: 8611408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-Aminolaevulinic acid-induced protoporphyrin IX accumulation in tissues: pharmacokinetics after oral or intravenous administration.
    van den Boogert J; van Hillegersberg R; de Rooij FW; de Bruin RW; Edixhoven-Bosdijk A; Houtsmuller AB; Siersema PD; Wilson JH; Tilanus HW
    J Photochem Photobiol B; 1998 Jun; 44(1):29-38. PubMed ID: 9745726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy.
    Fang YP; Tsai YH; Wu PC; Huang YB
    Int J Pharm; 2008 May; 356(1-2):144-52. PubMed ID: 18325699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo pharmacokinetics of protoporphyrin IX accumulation following intracutaneous injection of 5-aminolevulinic acid.
    de Blois AW; Thissen MR; de Bruijn HS; Grouls RJ; Dutrieux RP; Robinson DJ; Neumann HA
    J Photochem Photobiol B; 2001 Aug; 61(1-2):21-9. PubMed ID: 11485844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A time course investigation of the fluorescence induced by topical application of 5-aminolevulinic acid and methyl aminolevulinate on normal human skin.
    Lesar A; Ferguson J; Moseley H
    Photodermatol Photoimmunol Photomed; 2009 Aug; 25(4):191-5. PubMed ID: 19614897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microscopic localisation of protoporphyrin IX in normal mouse skin after topical application of 5-aminolevulinic acid or methyl 5-aminolevulinate.
    de Bruijn HS; Meijers C; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
    J Photochem Photobiol B; 2008 Aug; 92(2):91-7. PubMed ID: 18571933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of early stages of carcinogenesis in adenomas of murine lung by 5-aminolevulinic acid-induced protoporphyrin IX fluorescence.
    Campbell DL; Gudgin-Dickson EF; Forkert PG; Pottier RH; Kennedy JC
    Photochem Photobiol; 1996 Oct; 64(4):676-82. PubMed ID: 8863473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression levels of PEPT1 and ABCG2 play key roles in 5-aminolevulinic acid (ALA)-induced tumor-specific protoporphyrin IX (PpIX) accumulation in bladder cancer.
    Hagiya Y; Fukuhara H; Matsumoto K; Endo Y; Nakajima M; Tanaka T; Okura I; Kurabayashi A; Furihata M; Inoue K; Shuin T; Ogura S
    Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):288-95. PubMed ID: 23993855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging of hypoxia, oxygen consumption and recovery in vivo during ALA-photodynamic therapy using delayed fluorescence of Protoporphyrin IX.
    Scholz M; Petusseau AF; Gunn JR; Shane Chapman M; Pogue BW
    Photodiagnosis Photodyn Ther; 2020 Jun; 30():101790. PubMed ID: 32344195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protoporphyrin IX fluorescence and photobleaching during interstitial photodynamic therapy of malignant gliomas for early treatment prognosis.
    Johansson A; Faber F; Kniebühler G; Stepp H; Sroka R; Egensperger R; Beyer W; Kreth FW
    Lasers Surg Med; 2013 Apr; 45(4):225-34. PubMed ID: 23533060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical study in cats of the pro-photosensitizer 5-aminolevulinic acid.
    Lucroy MD; Edwards BF; Peavy GM; Krasieva TB; Griffey SM; Stiles JB; Madewell BR
    Am J Vet Res; 1999 Nov; 60(11):1364-70. PubMed ID: 10566810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.